Prelude Therapeutics Inc (NAS:PRLD)
$ 1.06 -0.08 (-7.02%) Market Cap: 58.34 Mil Enterprise Value: -77.15 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 32/100